All abstracts

All Posters

Topics

Clear all filters

ADAPTED NUTRIPAL SCREENING AND OVERALL SURVIVAL IN CANCER PATIENTS IN PALLIATIVE CARE

MORPHOFUNCTIONAL DIFFERENCES ACCORDING TO AGE IN PATIENTS WITH CANCER: A COMPARATIVE ANALYSIS BETWEEN PATIENTS AGED <65 AND ≥65 YEARS

PROGNOSTIC IMPACT OF GLIM-DEFINED MALNUTRITION AND PHASE ANGLE IN PATIENTS WITH DIGESTIVE TUMORS

IMPACT OF MYOSTEATOSIS, SYSTEMIC INFLAMMATION AND LOW CAQUEXIA INDEX IN PATIENTS WITHCOLON CANCER

EARLY MORPHOFUNCTIONAL STATUS DECLINE PREDICTS 12-MONTH MORTALITY IN ACUTE LEUKEMIA PATIENTS UNDERGOING CHEMOTHERAPY

TNFAIP8L1-INTEGRATED NOMOGRAM FOR POSTOPERATIVE SURVIVAL STRATIFICATION IN STAGE II-III COLON CANCER

TASTE ALTERATIONS WORSEN, BUT DO NOT DRIVE NUTRITIONAL RISK IN CHILDREN WITH SOLID TUMORS

MEASURED VERSUS ESTIMATED ENERGY REQUIREMENTS IN HOSPITALIZED PATIENTS WITH CANCER: THE ROLE OF INDIRECT CALORIMETRY

BRIDGING THE GAP BETWEEN NUTRITIONAL GUIDELINES AND CLINICAL PRACTICE IN ROMANIANONCOLOGY PATIENTS: A CROSS-SECTIONAL SURVEY

SEX-RELATED DIFFERENCES IN TUMOR SITE, MALNUTRITION SEVERITY AND SARCOPENIA IN CANCER PATIENTS WITH MALNUTRITION: ANYVIDA SUBANALYSIS

BEYOND MALNUTRITION AND CACHEXIA: THE ROLE OF NUTRITIONAL INTERVENTIONS AND PHYSICAL ACTIVITY IN SURVIVAL OF METASTATIC PANCREATIC CANCER PATIENTS

MALNUTRITION IN PATIENTS WITH ADVANCED HEAD AND NECK CANCER:EXPLORING THE GLIM CRITERIA, ENERGY BALANCE AND HEALTH-RELATED QUALITY OF LIFE

POTENTIAL EFFECTS OF NUTRITIONAL STATUS ON TREATMENT OUTCOMES IN PEDIATRIC PATIENTS DIAGNOSED WITH B-ALL: A PROSPECTIVE RANDOMIZED STUDY

EARLY AND PROACTIVE NUTRITION PREHABILITATION FOR GASTROESOPHAGEAL CANCER

IMPACT OF 3-MONTH PROTEIN-RICH NUTRITIONAL SUPPORT ON SARCOPENIA IN CANCER PATIENTS AT A PUBLIC HOSPITAL

MORPHOFUNCTIONAL PHENOTYPE (MFP) IN AMBULATORY CANCER PATIENTS WITH DISEASE-RELATED MALNUTRITION (DRM): ASSOCIATIONS WITH SARCOPENIA AND GLOBAL LEADERSHIP INICIATIVE MALNUTRITION (GLIM) CRITERIA SEVERITY: ANYVIDA STUDY SUBANALYSIS

BASELINE TOTAL CHOLESTEROL (TCHOL) LEVELS AS SURROGATE MARKER OF MALNUTRITION IN PATIENTS (PTS) WITH ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) STARTING FIRST-LINE CHEMOTHERAPY

MORPHOFUNCTIONAL ASSESSMENT AS A KEY TOOL IN THE EVALUATION OF CANCER-RELATED MALNUTRITION

IMPACT AND ASSESSMENT OF NUTRITIONAL STATUS AND SYSTEMIC INFLAMMATORY RESPONSE ON POSTOPERATIVE OUTCOMES IN COLORECTAL CANCER PATIENTS

HDL AND LDL SUBFRACTIONS AS PREDICTORS OF SURVIVAL IN WOMEN WITH BREAST CANCER